Table 1 Clinical and histopathological charateristics of the two patients with SRC-FTC
Immunohistochemical markers | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Case no. | Gender | Age at surgery | FNA diagnosis | Histo-pathological diagnosis | SRC component (%) | Vascular or capsular invasion | Tumor size (mm) | ETE | pTNM v8 | TTF1 | THYR | PAX8 | CDX2 | PDX1 | Ki-67% |
1 | M | 71 | Bethesda IV | miFTC | > 50 | Capsular | 38 | No | pT2Nx | + | + | + | – | – | 4 |
2 | M | 51 | Bethesda III | miFTC | 30–50 | Capsular | 22 | No | pT2Nx | + | + | + | – | – | 1.9 |